Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuvotion
AddedFeb 16, 2024
UpdatedJun 18, 2026
Neuvotion

Neuvotion

Seed

Neuvotion: Innovating neurostimulation and AI solutions for rehabilitation and physical therapy.

HQ
Darien, CT, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Neuvotion, founded with a mission to restore independence for individuals with movement impairments, focuses on developing advanced neurostimulation and AI solutions for the rehabilitation and physical therapy markets. Their core vision is to enhance therapeutic outcomes through innovative brain-body interface (BBI) technology. Neuvotion's products integrate artificial intelligence, highly-focal stimulation, and brain-computer interface (BCI) compatibility, enabling clinicians to facilitate and monitor patient progress both in-person and remotely.

Notable figures affiliated with Neuvotion include experts in neurostimulation and AI, though specific names are not provided. The company has achieved significant milestones in developing its BBI technology, which promises to deliver unparalleled therapeutic value. Neuvotion's impact is seen in its potential to revolutionize rehabilitation practices, offering new hope and improved quality of life for patients with movement impairments.

Neuvotion - Quick Facts

When was Neuvotion founded?

Neuvotion was founded in 2019.

Where is Neuvotion's headquarters located?

Neuvotion's headquarters is located in Darien, CT, US.

When was Neuvotion's last funding round?

Neuvotion's most recent funding round was for $1.3M (USD) in April 2023.

How much has Neuvotion raised to-date?

As of Apr 13, 2023, Neuvotion has raised a total of $2.3M (USD).

How many employees does Neuvotion have?

Neuvotion has 2 employees as of Feb 4, 2024.

Neuvotion - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621340Offices of Physical, Occupational and Speech Therapists, and Audiologists
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified